Other Clinical Trial - Follow-up of Patients After Knee NCT00284297

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Details — Status: Completed

Follow-up of patients who underwent a knee arthrodesis with different types of intramedullary nails.

Recruitment information / eligibility
Status	Completed
Enrollment	20
Est. completion date	July 2015
Est. primary completion date	July 2015
Accepts healthy volunteers	No
Gender	All
Age group	18 Years and older
Eligibility	Inclusion Criteria: - All patients who underwent a knee arthrodesis with an intramedullary nail between 1994 and 2005 Exclusion Criteria: -

Procedure:
• History taken and clinical examination
History is taken and clinical examination is followed

Locations
Country	Name	City	State
Belgium	University Hospital Ghent	Ghent

Sponsors *(1)*
Lead Sponsor	Collaborator
University Hospital, Ghent

Belgium,

Outcome
Type	Measure	Description	Time frame	Safety issue
Primary	Follow-up of patients who underwent a knee arthrodesis with different types of intramedullary nails		t0